NSC | Compound | Enrichment | Correlation |
---|---|---|---|
NSC 763564 | EMD-534085 | 0.0284045326811618 | -0.12563024 |
NSC 83066 | 8-Quinolinol, 5-(chloromethyl)-, hydrochloride | 0.0284045326811618 | -0.25915238 |
NSC 13275 | Null | 0.0286383688883668 | -0.065094396 |
NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.0286383688883668 | -0.081698065 |
NSC 15795 | Null | 0.0286383688883668 | -0.18114191 |
NSC 21683 | Null | 0.0286383688883668 | -0.29522593 |
NSC 28608 | Null | 0.0286383688883668 | -0.42048209 |
NSC 295499 | Camptothecin Derivative | 0.0286383688883668 | 0.056928416 |
NSC 31780 | 3H-Indolium, 2-[3-(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)-1-propenyl]-1,3,3-trimethyl-, chloride (9CI) | 0.0286383688883668 | -0.32696229 |
NSC 319947 | 2,4-Pyrimidinediamine, 5-(3-azido-4-chlorophenyl)-6-ethyl- | 0.0286383688883668 | -0.39462113 |